Long term follow-up of the PRIMA study: half of patients receiving rituximab maintenance remain progression free at 10 years GA Salles, JF Seymour, P Feugier, F Offner, A Lopez-Guillermo, D Belada, ... Blood 130, 486, 2017 | 65 | 2017 |
Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma TH Chen‐Liang, T Martín‐Santos, A Jerez, G Rodríguez‐García, L Senent, ... Cancer medicine 6 (11), 2507-2514, 2017 | 18 | 2017 |
Cuidados en los últimos días de vida en los pacientes hospitalizados en medicina interna J Díez-Manglano, SI de Isasmendi Pérez, MR Gómez, F Formiga, ... Revista Clínica Española 219 (3), 107-115, 2019 | 15 | 2019 |
Phase II study of yttrium-90-ibritumomab tiuxetan as part of reduced-intensity conditioning (with melphalan, fludarabine±thiotepa) for allogeneic transplantation in relapsed or … M Cabrero, A Martin, J Briones, J Gayoso, I Jarque, J López, C Grande, ... Biology of Blood and Marrow Transplantation 23 (1), 53-59, 2017 | 15 | 2017 |
Las cuestiones ético-jurídicas más relevantes en relación con los biobancos A Martín, MC Martín-Arribas, JH di Donato, M Posada Instituto de Salud Carlos III. Madrid, 2005 | 14 | 2005 |
Palliative sedation in patients hospitalized in internal medicine departments J Díez-Manglano, SI de Isasmendi Pérez, RG Fenoll, LÁ Sánchez, ... Journal of Pain and Symptom Management 59 (2), 302-309, 2020 | 12 | 2020 |
Una experiencia dentro de la conceptualización personalizada en el aula de infantil: las matemáticas y el cuerpo humano A Mateos Martín, J Macías Sánchez, B Arteaga Martínez | 11 | 2016 |
Safety and preliminary antitumor activity of the anti-PD-1 monoclonal antibody REGN2810 alone or in combination with REGN1979, an anti-CD20 x anti-CD3 bispecific antibody, in … MS Topp, P Borchmann, ND Wagner-Johnston, M Provencio, R Cordoba, ... Blood 130, 1495, 2017 | 10 | 2017 |
Progression‐free survival at 2 years post‐autologous transplant: a surrogate end point for overall survival in follicular lymphoma A Jiménez‐Ubieto, C Grande, D Caballero, L Yáñez, S Novelli, ... Cancer Medicine 6 (12), 2766-2774, 2017 | 10 | 2017 |
Post relapse survival rates in diffuse large B-cell lymphoma A McMillan, A Martín, C Haioun, A Chiappella, A Di Rocco, A Rueda, ... Blood 128 (22), 4204, 2016 | 10 | 2016 |
A new graphic cryptosystem based on one-dimensional memory cellular automata G Alvarez, A Hernandez, L Hernandez, A Martin, G Rodriguez Proceedings 39th annual 2005 international carnahan conference on security …, 2005 | 8 | 2005 |
DíAz, y A MArTin MiloslAviCh, P., es-CoBAr-Briones, e., guerrA-gArCíA, JM, orTiz, M …, 2013 | 6 | 2013 |
Prognostic significance of unplanned start of dialysis. A Spanish multicentrical study JL Górriz, A Sancho, LM Pallardó, ML Amoedo, A Martin, P Sanz, G Barril, ... Nefrología 22 (1), 49-59, 2002 | 4 | 2002 |
Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large B-cell lymphoma: Final results of the R2-GDP-GOTEL trial. L de la Cruz Merino, A Martin, E Nogales Fernandez, ... Journal of Clinical Oncology 38 (15_suppl), 8019-8019, 2020 | 3* | 2020 |
Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León JA Rodríguez-García, L Vázquez, F Ramos, B Cuevas, A Martín, ... Medicina Clínica 144 (11), 491-500, 2015 | 3 | 2015 |
The Presence of Residual Normal Plasma Cells by Multiparameter Flow Cytometry in the Bone Marrow of Symptomatic Multiple Myeloma Patients at Diagnosis Identifies A Good … B Paiva, M Vidriales, J Cervero, G Mateo, J Perez, MA Montalban, ... Haematologica-the Hematology Journal, 2012 | 3 | 2012 |
Development of a global-through-urban scale nested air quality forecast model (RSM-ANA): Application over the Madrid domain RS JosÉ, I Salas, A MartÍn, JL Pérez, AB Carpintero, MC Ramos, JI Pena, ... Systems Analysis Modelling Simulation 42 (11), 1551-1560, 2002 | 3 | 2002 |
Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients … E González-Barca, E Carrillo-Cruz, C Grande, A Martín, M Coronado, ... Blood 128 (22), 4201, 2016 | 2 | 2016 |
Prognostic Value of Interim PET/CT in Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL). Experience of the Spanish Geltamo Group M Coronado, E Pardal, R Couto, F de la Cruz, C Panizo, C Grande, ... Blood, The Journal of the American Society of Hematology 120 (21), 5076-5076, 2012 | 2 | 2012 |
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome A Martín, MD Caballero Haematologica 94 (5), 744-744, 2009 | 2 | 2009 |